Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters

Experimental Hematology

Volumn 27, Issue 12, 1999, Pages 1806-1814

  Voermans, Carlijn ^a,b   Gerritsen, Winald R ^c   Von Dem Borne, Albert E G Kr ^d   Van Der Schoot, C Ellen ^b,d  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Sanquin Blood Supp Found Lab E   (Netherlands)

^c Center for Liver   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CXCR 4; Fibronectin; Hematopoietic progenitor cells; Migration; SDF 1

Indexed keywords

CD34 ANTIGEN; CHEMOKINE; FIBRONECTIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD;

BONE MARROW; CELL MOVEMENT; FETAL BLOOD; FIBRONECTINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0032723979     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00113-7     Document Type: Article

References (42)

1. To L.B., Haylock D.N., Simmons P.J., Juttner C.A. The biology and clinical uses of blood stem cells. Blood. 89:1997;2233.
2. Elias A.D., Ayash L.A., Anderson K.C., Hunt M., Wheller C., Schwartz G., Tepler I., Mazanet R., Lynch C., Pap S., Paleaz J., Reich E., Critchlow J., Demetri G., Bibbo J., Schnipper L., Griffin J.D., Frei E., Antman K.H. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood. 79:1992;3036.
3. Tavassoli M., Hardy C.L. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood. 76:1990;1059.
4. Gordon M.Y., Blackett N.M. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant. 15:1995;659.
5. + cells and rapid recovery after peripheral blood stem cell transplantation. J Clin Oncol. 13:1995;1922.
6. + cells predict a rapid platelet recovery after peripheral blood stem cell transplantation Blood. 85:1995;3313.
7. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration. the multistep paradigm Cell. 76:1994;301.
8. Zannettino A.C.W., Berndt M.C., Butcher E.C., Vadas M.A., Simmons P.J. Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood. 85:1995;3466.
9. + cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood. 86:1995;3771.
10. Schweitzer CM, Vicart P, Delouis C, Paulin D, Dräger, Langenhuijsen MMAC, Weksler BB (1997) Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 76:25.
11. Levesque J.P., Leavesley D.I., Niutta S., Vadas M., Simmons P.J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med. 181:1995;1805.
12. + hemopoietic progenitors. Blood. 88:1996;1168.
13. Kovach N.L., Lin Y., Yednock T., Harlan J.M., Broudy V.C. Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood. 85:1995;159.
14. + progenitors to peripheral blood. J Exp Med. 185:1997;111.
15. + cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood. 91:1998;1196.
16. + and mature hematopoietic cells. an in vitro study using a human bone marrow endothelial cell line Blood. 89:1997;72.
17. Turner M.L., Maser L.C., Hardy C.L., Parker A.C., Sweetenham J.W. Comparative adhesion of human heamatopoietic cell lines to extracellular matrix components, bone marrow stromal and endothelial cultures. Br J Hematol. 100:1998;112.
18. + cells to fibronectin in an activation-dependent way. Blood. 81:1993;344.
19. van der Schoot C.E., Dercksen M.W. Mobilization and homing of haematopoietic progenitor cells. Vox Sang. 67:1994;221.
20. Rollins B.J. Chemokines. Blood. 90:1997;909.
21. Kim C.H., Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants. stromal cell-derived factor-1, steel factor, and the bone marrow environment Blood. 91:1998;100.
22. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 91:1998;4523.
23. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 184:1996;1101.
24. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV entry. Nature. 382:1996;829.
25. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.-L., Arenzana-Seisdedos F., Schwartz O., Heard J.-M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature. 382:1996;833.
26. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., Moser B. Cloning of a human seven-transmembrane domain receptor LESTR, that is highly expressed in leukocytes. J Biol Chem. 269:1994;232.
27. + hematopoietic progenitor cells. Blood. 89:1997;3522.
28. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:1996;635.
29. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A. 95:1998;9448.
30. Zou Y.-R., Kottmann A.H., Kudora M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:1998;595.
31. Peled A., Petit A., Kollet O., Magid M., Ponomatyov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 283:1999;845.
32. Rubenstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkowitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E., Stevens C.E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 339:1998;1665.
33. Tanabe S., Heesen M., Yoshizawa I., Bermans M.A., Luo Y., Bleul C.C., Springer T.A., Okuda K., Gerard N., Dorf M.E. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol. 159:1997;905.
34. Almici C., Carlo-Stella C., Wagner J.E., Mangoni L., Garau D., Rizzoli V. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood. Leukemia. 11:1997;2143.
35. 1 cell cycle status of mobilized hematopoietic stem cell from peripheral blood. Blood. 89:1997;465.
36. + cells is not restricted to the more primitive subfraction. Leukemia. 12:1998;571.
37. 2/M phases of the cell cycle. Blood. 92:1998;842.
38. Stossel TP (1994) The E. Donnall Thomas Lecture, 1993. The machinery of blood cell movements. Blood 84:367.
39. Stossel TP (1994) The E. Donnall Thomas Lecture, 1993. The machinery of blood cell movements. Blood 84:367.
40. 1 integrin-mediated adhesion and migration on human hematopoietic progenitor cells. Blood 90:1858.
41. Francis K., Ramakrishna R., Holloway W., Palsson B.O. Two new pseudopod morphologies displayed by the human hematopoietic KG1a progenitor cell line and by primary human CD34(+) cells. Blood. 92:1998;3616.
42. Kovach N.L., Carlos T.M., Yee E., Harlan J.M. A monoclonal antibody to beta 1 integrins (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J Cell Biol. 116:1992;499.